Archives

Pegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

B CARY, N.C., April 22, 2026 /PRNewswire/ — Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, announced today that pegrizeprument… Login to continue reading Login…

Read MorePegrizeprument Granted Orphan Drug Designation for Prevention of Organ Rejection in Heart Transplant Patients

Kyndryl Expands Distributed Cloud Services with Google Cloud to Accelerate Sovereign and AI-Ready Application Modernization

B New services extend cloud capabilities into customer environments, enabling workloads to run where data, regulatory or performance goals demand NEW YORK, April 22, 2026… Login to continue reading Login…

Read MoreKyndryl Expands Distributed Cloud Services with Google Cloud to Accelerate Sovereign and AI-Ready Application Modernization